Tech Company Financing Transactions
AllRock Bio Funding Round
Versant Ventures, Westlake Village BioPartners and private investors invested in a $50 million Series A capital raise for AllRock Bio. The round closed on 9/16/2025.
Transaction Overview
Company Name
Announced On
9/16/2025
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Versant Ventures (Lead Investor)
Westlake Village BioPartners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its lead molecule, ROC-101, which the company exclusively licensed from Sanofi, into Phase 2 clinical development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12 Washington Street, Second Floor
Natick, MA 01760
USA
Natick, MA 01760
USA
Phone
Undisclosed
Website
Email Address
Overview
AllRock Bio is leveraging extensive expertise from drug development to commercialization. AllRock Bio's team is dedicated to advancing impactful therapies for cardiopulmonary diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Catherine Pearce
Browse more venture capital transactions:
Prev: 9/16/2025: CreatorDB venture capital transaction
Next: 9/16/2025: PayNearMe venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs